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Learning point for clinicians
Radiological signs of pulmonary tularaemia can be indis-
tinguishable from lung cancer, and putatively character-
istic CT or even PET/CT images can easily mislead to
premature diagnosis of malignancy. Therefore, tular-
aemia should be considered when unspecific symptoms
of pneumonia are present, and the patient has an occu-
pation or hobby at risk.
Case report
A 41-year-old IT specialist was referred with suspected meta-
static lung cancer upon an 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography/computed tomography (PET/CT)
revealing a high tracer uptake in the enlarged hilar lymph nodes
of the right lung, and in several mediastinal and periportal
lymph nodes (Figure 1). Two weeks earlier he had consulted his
GP with sudden onset of malaise, growing pains, low-grade
fever, headache with scintillating scotoma, sore throat and an
itching exanthema of the upper part of his body. His otherwise
medical history was uneventful including absence of previous
illnesses, no medication and no recent travel abroad. He denied
cigarette smoking, alcohol or illicit drug abuse. Physical examin-
ation was unremarkable aside from a body temperature of
37.6C and decreased oxygen saturation of 94% on ambient air.
Lung auscultation and palpation of the lymph nodes were nor-
mal. Laboratory studies revealed mild leucocytosis (leucocytes
11.3  103/ml) with 80% neutrophiles and mildly elevated C-
reactive protein (25 mg/l). As an enlarged right-sided hilar re-
gion had been visible on chest X-ray, a CT scan had been added,
revealing unilateral mediastinal and hilar lymphadenopathy,
and an upper lobe consolidation. After conventional bronchos-
copy including transbronchial needle aspiration (TBNA) and
transbronchial forceps biopsy had failed to deliver the proof of
malignancy, an 18F-FDG-PET/CT and referral for endobronchial
ultrasound (EBUS)-guided TBNA were initiated. Cytological
examination of EBUS-TBNA smears taken from the lymph
nodes 4R, 10R and 11R showed morphologically normal
lymphocytes beside detritus, neutrophils and granuloma-like
aggregates of epithelioid macrophages with no evidence of ma-
lignancy. After interdisciplinary discussion between staff of the
departments of pathology and pulmonology the question of the
patient’s leisure activities came up. As the patient was a dedi-
cated hunter, polymerase chain reaction (PCR) for Francisella
tularensis on the cell block material was ordered and orally
ciprofloxacin 500 mg bid was begun empirically. Diagnosis of
glandular and presumably pneumonic tularaemia was con-
firmed after PCR detection and positive serologic testing
(marked positive IgG and IgM) for F. tularensis. Culture plates
grew only throat bacteria. Two weeks later, the patient fully re-
covered, and the lesions disappeared completely in a follow-up
CT scan.
Discussion
Tularaemia is a rare zoonotic infection caused by F. tularensis, a
Gram-negative bacterium which is typically acquired after con-
tact with contaminated animals by air- or tick-borne spread.
After an average incubation period of 3–5 days the disease has
an abrupt onset of non-specific symptoms including fever,
chills, malaise, headache, fatigue and growing pains. Additional
symptoms depend on the site of infection classifying tular-
aemia into ulcero-glandular, glandular, oculo-glandular, oro-
pharyngeal, typhoidal or pneumonic forms.1 Our patient
presented with unspecific symptoms along with unilateral hilar
enlargement and a pneumonic infiltrate. Due to high metabolic
activity of several mediastinal, hilar and abdominal lymph
nodes detected in the 18F-FDG-PET/CT suspicion of metastatic
lung cancer had arisen. However, according to a recently
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published case series, PET/CT scans of pulmonary tularaemia
can be indistinguishable from lung cancer, and putatively char-
acteristic CT or even PET/CT images can easily mislead to pre-
mature diagnosis of malignancy.2 In the present case, the hint
to diagnosis was given after interdisciplinary discussion and
thorough patient history highlighting these issues in the diag-
nostic work-up of a patient presenting with hilar lymphadenop-
athy of unknown cause. Tularaemia should be considered when
unspecific symptoms and/or clinical signs of pneumonia are
present, and the patient has an occupation or hobby at risk
including farming, landscaping and hunting.3,4
Francisellatularensis can be rapidly detected by PCR with favour-
able sensitivity and specificity on different biopsy materials,5
i.e. EBUS-guided fine needle aspirates posing an elegant
and non-invasive technique with a low procedure related
morbidity.
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Figure 1. PET/CT scan. Maximum intensity projection 60 min after injection of
352 MBq 18F-FDG, showing metabolically active right-sided hilar lymph nodes.
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